Company intelligence / Profile preview

Sirica Therapeutics

Ownership: Private
Development stage: Preclinical

Overview

Sirica Therapeutics has developed a proprietary digital therapeutic platform for cognitive sensorimotor therapy targeting children with autism spectrum disorder. The approach integrates virtual reality environments with robotics and physical activity to improve social, cognitive, physical, and behavioral symptoms. No published clinical results or regulatory approvals are available as of June 2025.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceDigital therapeutic system (includes Virtual reality, Robotics, Physical exercise integration)Cognitive sensorimotor therapy (proprietary digital modality)
Industry: Digital Health Medical Devices

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Sirica Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirica Therapeutics.

Explore the full profile